Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma-Reference-Cited by-同舟云学术

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma

Published:2002-07-23 Issue:3 Volume:95 Page:576-580
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tomita Naoto,Kodama Fumio,Kanamori Heiwa,Motomura Shigeki,Ishigatsubo Yoshiaki

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference13 articles.

1. Meningeal involvement in non-Hodgkin's lymphoma: Symptoms, incidence, risk factors and treatment

2. Secondary central nervous system involvement by non-Hodgkin's lymphoma: The risk factors

3. National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

4. Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults With Intermediate-Grade and Immunoblastic Lymphoma

5. Isolated Central Nervous System Relapse in Aggressive Non-Hodgkin's Lymphoma: the Bologna Experience

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A survey evaluating hematology physicians’ perspectives on central nervous system prophylaxis;Blood Research;2023-06-08

2. Novel cell delivery systems: Intracranial and intrathecal;NK Cells in Cancer Immunotherapy: Successes and Challenges;2023

3. Adrenal Lymphoma: Case Reports and Mini-review;International Journal of Endocrinology and Metabolism;2022-08-20

4. Central nervous system (CNS) prophylaxis in antiCD20-CHOP treated DLBCL at intermediate to high risk for CNS relapse: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2021-11

5. Delivery of Antineoplastic Therapeutics to the Central Nervous System;Cancer Regional Therapy;2019-12-11